1. Home
  2. QURE vs AIO Comparison

QURE vs AIO Comparison

Compare QURE & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • AIO
  • Stock Information
  • Founded
  • QURE 1998
  • AIO 2019
  • Country
  • QURE Netherlands
  • AIO United States
  • Employees
  • QURE N/A
  • AIO N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • AIO Finance/Investors Services
  • Sector
  • QURE Health Care
  • AIO Finance
  • Exchange
  • QURE Nasdaq
  • AIO Nasdaq
  • Market Cap
  • QURE 860.8M
  • AIO 760.3M
  • IPO Year
  • QURE 2007
  • AIO N/A
  • Fundamental
  • Price
  • QURE $15.18
  • AIO $24.84
  • Analyst Decision
  • QURE Strong Buy
  • AIO
  • Analyst Count
  • QURE 8
  • AIO 0
  • Target Price
  • QURE $33.00
  • AIO N/A
  • AVG Volume (30 Days)
  • QURE 1.2M
  • AIO 141.5K
  • Earning Date
  • QURE 02-26-2025
  • AIO 01-01-0001
  • Dividend Yield
  • QURE N/A
  • AIO 9.05%
  • EPS Growth
  • QURE N/A
  • AIO N/A
  • EPS
  • QURE N/A
  • AIO N/A
  • Revenue
  • QURE $28,587,000.00
  • AIO N/A
  • Revenue This Year
  • QURE $153.92
  • AIO N/A
  • Revenue Next Year
  • QURE N/A
  • AIO N/A
  • P/E Ratio
  • QURE N/A
  • AIO N/A
  • Revenue Growth
  • QURE N/A
  • AIO N/A
  • 52 Week Low
  • QURE $3.73
  • AIO $15.09
  • 52 Week High
  • QURE $19.18
  • AIO $20.25
  • Technical
  • Relative Strength Index (RSI)
  • QURE 52.73
  • AIO 60.12
  • Support Level
  • QURE $13.70
  • AIO $23.90
  • Resistance Level
  • QURE $15.18
  • AIO $24.64
  • Average True Range (ATR)
  • QURE 1.07
  • AIO 0.59
  • MACD
  • QURE -0.54
  • AIO 0.04
  • Stochastic Oscillator
  • QURE 29.76
  • AIO 95.50

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: